13D/G large-stake feed

Latest 13D/G Reports

Since 04 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

MANULIFE FINANCIAL CORP stake in Mobileye Global Inc.

Holder CIK 0001086888

13G/A MBLY
CIK
0001086888
Issuer
Mobileye Global Inc.
Security
MBLY
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
0% / 0 shares
Filed
15 May 2026, 17:19:09 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

K2 HealthVentures Equity Trust LLC stake in Neumora Therapeutics, Inc.

Holder CIK 0001948604

13G/A NMRA
CIK
0001948604
Issuer
Neumora Therapeutics, Inc.
Security
NMRA
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
3.1% / 5,790,453 shares
Filed
15 May 2026, 17:16:47 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

MANULIFE FINANCIAL CORP stake in Landmark Bancorp, Inc.

Holder CIK 0001086888

13G/A LARK
CIK
0001086888
Issuer
LANDMARK BANCORP INC
Security
LARK
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
0% / 0 shares
Filed
15 May 2026, 17:16:11 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Tompkins Mark N. stake in Deep Isolation Nuclear, Inc.

Holder CIK 0001455971

13G/A CUSIP NOTAPPLICABL
CIK
0001455971
Issuer
Deep Isolation Nuclear, Inc.
Security
CUSIP NOTAPPLICABL
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.5% / 3,150,000 shares
Filed
15 May 2026, 17:15:54 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Stonepine Capital Management, LLC stake in Edesa Biotech, Inc.

Holder CIK 0001440771

13G/A EDSA
CIK
0001440771
Issuer
Edesa Biotech, Inc.
Security
EDSA
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
0.3% / 30,000 shares
Filed
15 May 2026, 17:15:00 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Extract Advisors LLC stake in NexMetals Mining Corp.

Holder CIK 0001703148

13G/A NEXM
CIK
0001703148
Issuer
NexMetals Mining Corp.
Security
NEXM
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.4% / 1,971,622 shares
Filed
15 May 2026, 17:14:22 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
601-650 of 4,014
Per page
50
Current page
13

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

5.5%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

MANULIFE FINANCIAL CORP

Mobileye Global Inc. (MBLY)

Schedule 13G/A Ownership 0% Filing-backed
CIK
000114544326000065
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
0%
Filed
15 May 2026, 17:19:09 UTC
Period
31 Mar 2026

MANULIFE FINANCIAL CORP filed Schedule 13G/A for Mobileye Global Inc. (MBLY). Reported class ownership: 0%. Ownership change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

K2 HealthVentures Equity Trust LLC

Neumora Therapeutics, Inc. (NMRA)

Schedule 13G/A Ownership 3.1% Filing-backed
CIK
000090514826002417
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
3.1%
Filed
15 May 2026, 17:16:47 UTC
Period
31 Mar 2026

K2 HealthVentures Equity Trust LLC filed Schedule 13G/A for Neumora Therapeutics, Inc. (NMRA). Reported class ownership: 3.1%. Ownership change: -1.9%. Share change: -36%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

MANULIFE FINANCIAL CORP

Landmark Bancorp, Inc. (LARK)

Schedule 13G/A Ownership 0% Filing-backed
CIK
000114544326000064
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
0%
Filed
15 May 2026, 17:16:11 UTC
Period
31 Mar 2026

MANULIFE FINANCIAL CORP filed Schedule 13G/A for Landmark Bancorp, Inc. (LARK). Reported class ownership: 0%. Ownership change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Tompkins Mark N.

Deep Isolation Nuclear, Inc.

Schedule 13G/A Ownership 5.5% Filing-backed
CIK
000121390026057958
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
5.5%
Filed
15 May 2026, 17:15:54 UTC
Period
31 Mar 2026

Tompkins Mark N. filed Schedule 13G/A for Deep Isolation Nuclear, Inc.. Reported class ownership: 5.5%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Stonepine Capital Management, LLC

Edesa Biotech, Inc. (EDSA)

Schedule 13G/A Ownership 0.3% Filing-backed
CIK
000093583626000278
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
0.3%
Filed
15 May 2026, 17:15:00 UTC
Period
31 Mar 2026

Stonepine Capital Management, LLC filed Schedule 13G/A for Edesa Biotech, Inc. (EDSA). Reported class ownership: 0.3%. Ownership change: -9.6%. Share change: -96%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Extract Advisors LLC

NexMetals Mining Corp. (NEXM)

Schedule 13G/A Ownership 5.4% Filing-backed
CIK
000170314826000016
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
5.4%
Filed
15 May 2026, 17:14:22 UTC
Period
02 Mar 2026

Extract Advisors LLC filed Schedule 13G/A for NexMetals Mining Corp. (NEXM). Reported class ownership: 5.4%. Ownership change: +0.4%. Share change: +7.5%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
MANULIFE FINANCIAL CORP CIK 0001086888 MBLY Mobileye Global Inc. 0 0% SEC filing
K2 HealthVentures Equity Trust LLC CIK 0001948604 NMRA Neumora Therapeutics, Inc. 5,790,453 3.1% SEC filing
MANULIFE FINANCIAL CORP CIK 0001086888 LARK Landmark Bancorp, Inc. 0 0% SEC filing
Tompkins Mark N. CIK 0001455971 CUSIP NOTAPPLICABL Deep Isolation Nuclear, Inc. 3,150,000 5.5% SEC filing
Stonepine Capital Management, LLC CIK 0001440771 EDSA Edesa Biotech, Inc. 30,000 0.3% SEC filing
Extract Advisors LLC CIK 0001703148 NEXM NexMetals Mining Corp. 1,971,622 5.4% SEC filing
Winklevoss Capital Fund, LLC CIK 0002085726 EMPD Empery Digital Inc. 2,228,351 7.9% SEC filing
MANULIFE FINANCIAL CORP CIK 0001086888 CZWI First Watch Restaurant Group, Inc. 0 0% SEC filing
MAK Capital Fund LP CIK 0001426156 CLPT ClearPoint Neuro, Inc. 1,901,489 6.3% SEC filing
Ensorcia Metals Corp CIK 0002134357 CUSIP 459121109 International Battery Metals Ltd. 18,568,831 5.4% SEC filing
Schlacks Jabbok CIK 0002091677 EQPT EquipmentShare.com Inc 34,778,852 15% SEC filing
QVT Financial LP CIK 0001290162 CMTL Comtech Telecommunications Corp. 1,694,467 5.7% SEC filing
Stonepine Capital Management, LLC CIK 0001440771 CNSP CNS Pharmaceuticals, Inc. 159,790 9.9% SEC filing
BERKSHIRE HATHAWAY INC CIK 0001067983 LILA LIBERTY LATIN AMERICA LTD 0 0% SEC filing
Vestal Point Capital, LP CIK 0001974915 TSHA Taysha Gene Therapies, Inc. 18,000,000 6.3% SEC filing
MANULIFE FINANCIAL CORP CIK 0001086888 EBMT Eagle Bancorp Montana, Inc. 0 0% SEC filing
Seven Fleet Capital Management LP CIK 0002092021 CTMX CytomX Therapeutics, Inc. 1,085,398 0.5% SEC filing
Khrom Investments Fund, LP CIK 0001586094 ACHC Acadia Healthcare Company, Inc. 5,201,533 5.7% SEC filing
Maple Rock Capital Partners Inc. CIK 0001658363 ASTL Algoma Steel Group Inc. 15,930,818 15% SEC filing
Vestal Point Capital, LP CIK 0001974915 BCAX Bicara Therapeutics Inc. 5,425,000 8.3% SEC filing
Vestal Point Capital, LP CIK 0001974915 ELVN Enliven Therapeutics, Inc. 3,250,000 5.4% SEC filing
Sculptor Capital LP CIK 0001054587 CEPS Cantor Equity Partners VI, Inc. 523,144 4.4% SEC filing
Extract Advisors LLC CIK 0001703148 AEC Anfield Energy Inc. 1,275,271 6.6% SEC filing
Vestal Point Capital, LP CIK 0001974915 ANRO Alto Neuroscience, Inc. 2,064,075 6.5% SEC filing
Vestal Point Capital, LP CIK 0001974915 IMTX Immatics N.V. 6,175,000 4.6% SEC filing
Caracola Ventures Corp CIK 0002125707 NUAI New ERA Energy & Digital, Inc. 5,050,000 8.6% SEC filing
Vestal Point Capital, LP CIK 0001974915 ACLX Arcellx, Inc. 0 0% SEC filing
Cinctive Capital Management LP CIK 0001787258 LZM Lifezone Metals Ltd 10,431,113 12% SEC filing
Vestal Point Capital, LP CIK 0001974915 DRUG BRIGHT MINDS BIOSCIENCES INC. 492,319 5% SEC filing
AMERICAN CAPITAL MANAGEMENT INC CIK 0001320168 CRNC Cerence, Inc 1,385,539 5.6% SEC filing
Vestal Point Capital, LP CIK 0001974915 NRIX Nurix Therapeutics, Inc. 6,500,000 6.3% SEC filing
Citadel Securities GP LLC CIK 0001721695 WULF TERAWULF INC. 15,840,234 3.7% SEC filing
Ikarian Capital, LLC CIK 0001778253 LPCN Lipocine Inc. 508,556 6.3% SEC filing
Vestal Point Capital, LP CIK 0001974915 APRE Aprea Therapeutics, Inc. 22,654,832 9.9% SEC filing
Darsana Capital Partners LP CIK 0001609098 WMG Warner Music Group Corp. 11,850,000 8.1% SEC filing
PointState Capital LP CIK 0001509842 STUB StubHub Holdings, Inc. 21,102,569 6.4% SEC filing
Darwin Global Management, Ltd. CIK 0001839209 INSM INSMED Inc 16,805,184 7.8% SEC filing
Vestal Point Capital, LP CIK 0001974915 IMCR Immunocore Holdings plc 2,766,868 5.5% SEC filing
HEDGEHOG CAPITAL LLC CIK 0001215763 BHM Bluerock Homes Trust, Inc. 250,279 6.1% SEC filing
Sculptor Capital LP CIK 0001054587 PALO Paloma Acquisition Corp I 674,100 4.4% SEC filing
Ikarian Capital, LLC CIK 0001778253 KPTI Karyopharm Therapeutics Inc. 0 0% SEC filing
Cinctive Capital Management LP CIK 0001787258 NTHI NEONC TECHNOLOGIES HOLDINGS, INC. 2,483,980 10% SEC filing
TENOR CAPITAL MANAGEMENT Co., L.P. CIK 0001346554 CAQUU Cambridge Acquisition Corp. 1,000,000 4.3% SEC filing
WARBURG PINCUS & CO. CIK 0000929408 SHC Sotera Health Co 0 0% SEC filing
BERKSHIRE HATHAWAY INC CIK 0001067983 NYT NEW YORK TIMES CO 15,146,535 9.4% SEC filing
BERKSHIRE HATHAWAY INC CIK 0001067983 STZ CONSTELLATION BRANDS, INC. 632,890 0.4% SEC filing
Ikarian Capital, LLC CIK 0001778253 PTHS Pelthos Therapeutics Inc. 256,598 7.7% SEC filing
Citadel Securities GP LLC CIK 0001721695 UONE URBAN ONE, INC. 1,866 0.3% SEC filing
Fourthstone LLC CIK 0001767803 BOTJ BANK OF THE JAMES FINANCIAL GROUP INC 385,498 8.5% SEC filing
CITADEL ADVISORS LLC CIK 0001423053 SNCY Sun Country Airlines Holdings, Inc. 1,342,124 2.5% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .